A detailed history of Financial Architects, Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Financial Architects, Inc holds 3,421 shares of AZN stock, worth $223,562. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,421
Previous 3,421 -0.0%
Holding current value
$223,562
Previous $237,000 2.95%
% of portfolio
0.04%
Previous 0.04%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$63.15 - $71.6 $15,724 - $17,828
249 Added 7.85%
3,421 $237,000
Q4 2022

Feb 06, 2023

BUY
$54.21 - $70.44 $171,954 - $223,435
3,172 New
3,172 $215,000
Q2 2022

Aug 11, 2022

SELL
$59.26 - $71.14 $17,778 - $21,342
-300 Reduced 8.9%
3,072 $203,000
Q1 2022

May 05, 2022

SELL
$55.72 - $67.12 $5,349 - $6,443
-96 Reduced 2.77%
3,372 $224,000
Q3 2021

Nov 12, 2021

BUY
$55.56 - $60.79 $166 - $182
3 Added 0.09%
3,468 $208,000
Q2 2021

Aug 10, 2021

BUY
$48.42 - $60.18 $167,775 - $208,523
3,465 New
3,465 $208,000
Q3 2020

Nov 09, 2020

SELL
$53.07 - $61.1 $162,288 - $186,843
-3,058 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$37.28 - $41.68 $13,607 - $15,213
-365 Reduced 10.66%
3,058 $126,000
Q1 2019

May 13, 2019

BUY
$35.49 - $43.02 $121,482 - $147,257
3,423 New
3,423 $138,000
Q1 2019

May 03, 2019

SELL
$35.49 - $43.02 $180,253 - $218,498
-5,079 Closed
0 $0
Q4 2018

Feb 01, 2019

BUY
$36.86 - $41.49 $81,829 - $92,107
2,220 Added 77.65%
5,079 $193,000
Q3 2018

Oct 29, 2018

SELL
$34.76 - $39.72 $45,014 - $51,437
-1,295 Reduced 31.17%
2,859 $113,000
Q2 2018

Aug 03, 2018

BUY
$34.55 - $37.05 $5,804 - $6,224
168 Added 4.21%
4,154 $146,000
Q1 2018

Apr 23, 2018

BUY
$32.97 - $36.63 $57,697 - $64,102
1,750 Added 78.26%
3,986 $140,000
Q4 2017

Feb 12, 2018

SELL
$32.09 - $34.78 $13,702 - $14,851
-427 Reduced 16.03%
2,236 $77,000
Q3 2017

Nov 01, 2017

BUY
$28.96 - $34.0 $77,120 - $90,542
2,663
2,663 $90,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Financial Architects, Inc Portfolio

Follow Financial Architects, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Financial Architects, Inc with notifications on news.